How Is Chronic Lymphocytic Luekemia Diagnosed?

This content has been reviewed and approved by

Hagop M. Kantarjian, MD
Chairman & Professor, Leukemia Department
MD Anderson Cancer Center
University of Texas
 

In addition to a complete medical history and physical examination, diagnostic procedures for chronic lymphocytic leukemia may include the following:

  • Additional blood tests and other evaluation procedures
  • Bone marrow aspiration and/or biopsy - a procedure that involves taking a small amount of bone marrow fluid (aspiration) and/or solid bone marrow tissue (called a core biopsy), usually from the hip bones, to be examined for the number, size, and maturity of blood cells and/or abnormal cells.
This content was last modified on August 11, 2007 .
Latest Chronic Lymphocytic Leukemia News
Green tea ingredient may fight incurable leukemia

June 4, 2009 — NEW YORK (Reuters Health) - A chemical found in green tea may shrink lymph nodes and reduce white blood cell counts in patients with chronic lymphocytic leukemia (CLL), a new study in the Journal of Clinical Oncology shows.

FDA advisers back Glaxo, Genmab cancer drug

May 29, 2009 — ORLANDO, Florida (Reuters) - A small trial of Arzerra, being developed by GlaxoSmithKline Plc and Genmab for treating chronic lymphocytic leukemia, indicated benefits sufficient for U.S. approval, an advisory committee to regulators said on Friday.

FDA staff questions data on leukemia drug

May 27, 2009 — WASHINGTON (Reuters) - U.S. drug reviewers questioned whether a proposed leukemia drug from GlaxoSmithKline PLC and Genmab provides enough benefit to warrant approval, documents released on Wednesday said.

Select news items provided by Reuters Health